These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16318164)

  • 1. Dissemination of health technology assessments: identifying the visions guiding an evolving policy innovation in Canada.
    Lehoux P; Denis JL; Tailliez S; Hivon M
    J Health Polit Policy Law; 2005 Aug; 30(4):603-41. PubMed ID: 16318164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redefining health technology assessment in Canada: diversification of products and contextualization of findings.
    Lehoux P; Tailliez S; Denis JL; Hivon M
    Int J Technol Assess Health Care; 2004; 20(3):325-36. PubMed ID: 15446762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of health technology assessment in decision making: coresponsibility of users and producers?
    Hivon M; Lehoux P; Denis JL; Tailliez S
    Int J Technol Assess Health Care; 2005; 21(2):268-75. PubMed ID: 15921069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland.
    Allen N; Walker SR; Liberti L; Salek S
    Value Health; 2017 Mar; 20(3):320-328. PubMed ID: 28292476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluations conducted by Canadian health technology assessment agencies: where do we stand?
    Tarride JE; McCarron CE; Lim M; Bowen JM; Blackhouse G; Hopkins R; O'Reilly D; Xie F; Goeree R
    Int J Technol Assess Health Care; 2008; 24(4):437-44. PubMed ID: 18828938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health technology assessment in Canada. A decade in review.
    Menon D; Topfer LA
    Int J Technol Assess Health Care; 2000; 16(3):896-902. PubMed ID: 11028144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What medical specialists like and dislike about health technology assessment reports.
    Lehoux P; Hivon M; Denis JL; Tailliez S
    J Health Serv Res Policy; 2009 Oct; 14(4):197-203. PubMed ID: 19770117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supporting the Use of Health Technology Assessments by Decision-Makers.
    Polisena J; Lavis JN; Juzwishin D; McLean-Veysey P; Graham ID; Harstall C; Martin J
    Healthc Policy; 2015 May; 10(4):10-5. PubMed ID: 26142355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-ordinating health technology assessment in Canada: a European perspective.
    McDaid D
    Health Policy; 2003 Feb; 63(2):205-13. PubMed ID: 12543533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modes of coordination for health technology adoption: Health Technology Assessment agencies and Group Procurement Organizations in a polycentric regulatory regime.
    Miller FA; Lehoux P; Rac VE; Bytautas JP; Krahn M; Peacock S
    Soc Sci Med; 2020 Nov; 265():113528. PubMed ID: 33261901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "It all depends": conceptualizing public involvement in the context of health technology assessment agencies.
    Gauvin FP; Abelson J; Giacomini M; Eyles J; Lavis JN
    Soc Sci Med; 2010 May; 70(10):1518-26. PubMed ID: 20207061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disinvestment in healthcare: an overview of HTA agencies and organizations activities at European level.
    Calabrò GE; La Torre G; de Waure C; Villari P; Federici A; Ricciardi W; Specchia ML
    BMC Health Serv Res; 2018 Mar; 18(1):148. PubMed ID: 29490647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using health technology assessment for better healthcare decisions.
    Tucker S; O'Brien K; Brown HM
    Healthc Manage Forum; 2019 Jul; 32(4):197-201. PubMed ID: 31091998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Requirements for and expectations of health technology assessment in Galicia (Spain). A qualitative study from the perspective of decision-makers and clinicians].
    Varela-Lema L; Merino GA; García ML; Martínez MV; Triana EG; Mota TC
    Gac Sanit; 2011; 25(6):454-60. PubMed ID: 21820766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health technology assessment.
    Hailey D
    Singapore Med J; 2006 Mar; 47(3):187-92; quiz 193. PubMed ID: 16518551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health technology assessment: research trends and future priorities in Europe.
    Nielsen CP; Funch TM; Kristensen FB
    J Health Serv Res Policy; 2011 Jul; 16 Suppl 2():6-15. PubMed ID: 21737525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health technology assessment use and dissemination by patient and consumer groups: why and how?
    Fattal J; Lehoux P
    Int J Technol Assess Health Care; 2008; 24(4):473-80. PubMed ID: 18828943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A regulatory governance perspective on health technology assessment (HTA) in France: the contextual mediation of common functional pressures.
    Barron AJ; Klinger C; Shah SM; Wright JS
    Health Policy; 2015 Feb; 119(2):137-46. PubMed ID: 25458970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.